AKR1B10 and breast carcinoma: In breast cancer, AKR1B10 protein is overexpressed in primary, metastatic, and recurrent diseases; AKR1B10 was also found to be upregulated in ductal carcinoma in situ (DCIS) (71.4%, n=28) (20).